Cannamedai S.A.

Other research and experimental development on natural sciences and engineering

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2022-01-24
Share capital
1,000,000.00 PLN
Activity description

Cannamedai is a company that specializes in the research and development of cannabis-based therapies, utilizing advanced AI algorithms to analyze large datasets from cannabis research. It focuses on improving the health outcomes of oncology patients by personalizing cannabis treatments to meet individual patient needs. The company collaborates with scientists, doctors, and regulators to ensure its innovations are scientifically validated and compliant with regulations.

Registered address
ul. Bartosza Głowackiego 25-27/8c, 45-110 Opole, Poland
Email
Phone

Financials

Revenue history (in k)

Filing timeliness

No financial statement for 2024 – the filing deadline has passed. 2 of 2 financial statements were filed late (the longest delay 391 days for 2022).

  • 2024not filed
  • 202316/01/2025
  • 202209/08/2024
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2023.

Division · Scientific research and development1,207 / 1,943
Top 62%
Voivodeship · Opolskie5,689 / 7,275
Top 78%
Country · Poland366,766 / 496,474
Top 74%

Results vs industry

Revenue
This companyUSD 28.20kMedianUSD 73.13kAverageUSD 3.24m
Net profit
This companyUSD -29.86kMedianUSD 69.70AverageUSD 83.06k
Operating costs
This companyUSD 56.40kMedianUSD 75.83kAverageUSD 3.05m
Assets
This companyUSD 171.74kMedianUSD 120.25kAverageUSD 3.90m

Offer

  • Research into cannabis-based therapies
  • Medical data analysis
  • Development of cannabis-based therapies
  • Personalised therapy
  • Cannabis-based medical products

Websites

  • cannamedai.comCannamedai S.A. – klinika konopi medycznych oparta na AI
    WordPress 3.7ElementorLiteSpeed

Authorized Representatives

Piotr Józef Wołąsewicz age 59 – President of the Management Board

Manner of representation

The company is represented by: 1. in the case of a one-person management board – the sole member of the management board acting independently. 2. in the case of a management board consisting of more than one person – two members of the management board jointly, or one member of the management board jointly with a commercial proxy. 3. The management board may incur obligations on behalf of the company or dispose of a right with a value not exceeding PLN 500,000.00 (five hundred thousand zlotys). Above this amount, it must obtain the consent of the supervisory board.

Supervisory board

Mariusz Ferdynand Kosmaty age 55 – Supervisory Board Member
Sebastian Jan Frank age 40 – Supervisory Board Member
Piotr Jan Kosmaty age 28 – Supervisory Board Member

Beneficial owners

Person

Bank accounts

Was a VAT taxpayer from 2022-02-15 to 2026-01-21.

Reason for removal: Art. 96 ust. 9a pkt 3 (VAT returns showing no transactions filed for 6 consecutive months or 2 quarters)

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Competitors

Name
Biostat Research and Development sp. z o.o.
Personather sp. z o.o.
Zawamed sp. z o.o.
Orphinic Scientific S.A.
Onconick sp. z o.o.
Biolabic sp. z o.o.
DR Joanna Sanford sp. k.
Inventro S.A.
Nanovelos S.A.
Emotin sp. z o.o.

Change history

DateEvent
2024-06-11Address change
2024-06-11Name change
2024-06-11PKD change
2024-02-29Address change
2022-05-16Address change

FAQ

Last updated: 2026-04-01